"Paraproteinemias" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin.
| Descriptor ID |
D010265
|
| MeSH Number(s) |
C15.378.147.780 C20.683.780
|
| Concept/Terms |
Paraproteinemias- Paraproteinemias
- Paraproteinemia
- Paraimmunoglobulinemias
- Paraimmunoglobulinemia
Plasma Cell Dyscrasias- Plasma Cell Dyscrasias
- Cell Dyscrasia, Plasma
- Cell Dyscrasias, Plasma
- Dyscrasia, Plasma Cell
- Dyscrasias, Plasma Cell
- Plasma Cell Dyscrasia
Gammopathy, Monoclonal- Gammopathy, Monoclonal
- Gammopathies, Monoclonal
- Monoclonal Gammopathy
- Monoclonal Gammopathies
- Gammapathy, Monoclonal
- Gammapathies, Monoclonal
- Monoclonal Gammapathy
- Monoclonal Gammapathies
|
Below are MeSH descriptors whose meaning is more general than "Paraproteinemias".
Below are MeSH descriptors whose meaning is more specific than "Paraproteinemias".
This graph shows the total number of publications written about "Paraproteinemias" by people in this website by year, and whether "Paraproteinemias" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 6 | 0 | 6 |
| 2018 | 4 | 0 | 4 |
| 2019 | 4 | 2 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Paraproteinemias" by people in Profiles.
-
Transient plasma cell dyscrasia in COVID-19 patients linked to IL-6 triggering. Microbes Infect. 2021 May-Jun; 23(4-5):104808.
-
Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias. Blood Adv. 2021 03 09; 5(5):1535-1539.
-
The impact of COVID-19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single-center experience. Eur J Haematol. 2021 Mar; 106(3):340-345.
-
Screening for Gaucher disease among patients with plasma cell dyscrasias. Leuk Lymphoma. 2021 03; 62(3):761-763.
-
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol. 2019 06; 20(6):e302-e312.
-
Fibrogenesis Imperfecta Ossium. Calcif Tissue Int. 2019 05; 104(5):561-569.
-
Effects of Long-Term Storage on Serum Free Light Chain Stability. Clin Lab. 2019 May 01; 65(5).
-
Necrobiotic Xanthogranuloma as the Presenting Manifestation of Smouldering Myeloma. J Assoc Physicians India. 2019 Mar; 67(3):87-88.
-
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol. 2019 01; 15(1):45-59.
-
European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias. Leukemia. 2018 09; 32(9):1883-1898.